Research Advances of Traditional Chinese Medicine in Cancer Immunotherapy
Open Access
- 28 December 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Chinese Medicine and Culture
- Vol. 3 (4) , 245-253
Abstract
Tumorigenesis are closely associated with the immune function of the human body. Immunotherapy has emerged as a novel and promising treatment strategy in multiple malignancies in the 21st century. Traditional Chinese medicine (TCM) has been extensively used for cancer treatment in China and surrounding countries for it exerts efficient therapeutic effects with few side effects. In recent years, studies have demonstrated that TCM plays a unique and reliable role in regulating tumor immunity. TCM can enhance the antitumor immune response function by regulating the secretion of cytokines, reshaping the balance of immune cells, and regulating immune checkpoints to relieve the immunosuppression. In addition, TCM can reduce the side effects (e.g., cytokine storm) of cancer immunotherapy. Based on the current research of active immunotherapy and passive immunotherapy, this review summarizes the potential applications and existing problems of TCM in tumor immunotherapy. This review may be helpful in illuminating the scientific basis of TCM in tumor immunotherapy, promoting its internationalization, as well as shedding innovating new strategies for the development of tumor immunotherapy.Keywords
This publication has 51 references indexed in Scilit:
- Multiple anti‐inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B‐induced lung injuryBritish Journal of Pharmacology, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer MicroenvironmentCancer Research, 2012
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinomaGut, 2011
- Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast CancerCancer Research, 2011
- Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAMCellular & Molecular Immunology, 2011
- Successful Treatment of Melanoma Brain Metastases with Adoptive Cell TherapyClinical Cancer Research, 2010
- History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success StoryJournal of Urology, 2008
- Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or MelanomaJournal of Experimental Medicine, 2002
- IMMUNOLOGICAL ASPECTS OF MALIGNANT DISEASEThe Lancet, 1967